KSC Equity Snapshot
950210 Weekly Equity Report
Prestige BioPharma Limited
What the company does
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research and development and marketing of biosimilars, antibody drugs, and vaccines in Singapore. The company offers Trastuzumab biosimilar for the treatment of breast cancer; Bevacizumab biosimilar for the treatment in oncology; and PBP1502, an adalimumab biosimilar, which is in Phase 1 clinical trial for the treatment in immunity. It also develops PBP1510, a first-in-class antibody, which is in phase 1/2a clinical trial for the treatment of pancreatic cancer; PBP1710, a first-in-class antibody that is in preclinical trials for the treatment of solid tumor and fibrosis; and …
What the weekly tape is saying
950210 closed the latest completed week at 6,960 KRW. The 4-week return is -10.5% and the 12-week return is -28.1%. Trend Signal is inactive, Market Dynamics is -1.69. Setup signature: Risk-first tape with a 11/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 10,504 KRW
- Vs Trend Line
- -33.7%
- Fair Value
- 11,836 KRW
- Vs Fair Value
- -41.2%
- 52W High
- 20,000 KRW
- 52W Low
- 6,140 KRW
- Drawdown
- -65.2%
- Range Position
- 5.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 8
- 52W Active Breadth
- 15.4%
- Sector Scope
- KR Healthcare
- Sector Rank
- 14 of 63
- Sector Percentile
- 79.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 22 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Biotechnology
- Tracked Peers
- 10
- 4W Rank
- 6 of 10
- Avg 1W
- -0.9%
- Avg 4W
- -11.2%
- Trend Breadth
- 0.0%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.69
- 4W MD Change
- -11.6%
- Relative Strength
- -70.86
- 4W RS Change
- -4.3%
- Expectation
- Negative
- Probability
- 42.63%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 400.5K
- 13W Average
- 459.6K
- 52W Average
- 759.0K
- Vs 13W
- 0.9x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.7%
- 52W Volatility
- 9.8%
- Upside Weeks
- 16
- Downside Weeks
- 36
- Downside Breadth
- 69.2%
- Avg Gain / Loss
- 8.3% / -4.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- KRW
- Market Cap
- 392.4B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 6,960 KRW | 2.5% | 10,504 KRW | 11,836 KRW | -1.69 | -70.86 | 400.5K | Off |
| 5 Jun 2026 | 6,790 KRW | -2.0% | 10,691 KRW | 11,858 KRW | -1.72 | -72.32 | 521.2K | Off |
| 29 May 2026 | 6,930 KRW | -11.2% | 10,862 KRW | 11,880 KRW | -1.69 | -73.46 | 411.2K | Off |
| 22 May 2026 | 7,800 KRW | 0.3% | 11,047 KRW | 11,900 KRW | -1.61 | -68.54 | 410.5K | Off |
| 15 May 2026 | 7,780 KRW | -2.8% | 11,200 KRW | 11,914 KRW | -1.52 | -67.93 | 571.2K | Off |
| 8 May 2026 | 8,000 KRW | -10.2% | 11,365 KRW | 11,926 KRW | -1.43 | -67.81 | 611.2K | Off |
| 1 May 2026 | 8,910 KRW | -3.4% | 11,528 KRW | 11,936 KRW | -1.51 | -60.23 | 336.9K | Off |
| 24 Apr 2026 | 9,220 KRW | -7.2% | 11,665 KRW | 11,939 KRW | -1.48 | -59.03 | 361.3K | Off |
| 17 Apr 2026 | 9,940 KRW | 8.8% | 11,805 KRW | 11,944 KRW | -1.32 | -54.95 | 426.7K | Off |
| 10 Apr 2026 | 9,140 KRW | -4.8% | 11,953 KRW | 11,952 KRW | -1.45 | -57.22 | 366.0K | Off |
| 3 Apr 2026 | 9,600 KRW | -6.6% | 12,137 KRW | 11,977 KRW | -1.47 | -52.16 | 345.9K | Off |
| 27 Mar 2026 | 10,280 KRW | 6.2% | 12,310 KRW | 11,992 KRW | -1.52 | -50.32 | 879.6K | Off |
| 20 Mar 2026 | 9,680 KRW | -0.6% | 12,424 KRW | 11,999 KRW | -1.55 | -56.71 | 333.0K | Off |
| 13 Mar 2026 | 9,740 KRW | -2.7% | 12,563 KRW | 12,009 KRW | -1.26 | -54.74 | 393.6K | Off |